Radiopharmaceuticals-lutathera and pluvicto injections
Active Awarded Last action
- Contract number
- 36C24426F0063
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,980,571
Award facts
- Contract value 100% obligated
- $1,980,570.88 Current and potential, with all options
- Completion date 80% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lebanon, PA 17042, USA
Award details come from SAM.gov/FPDS.
About this award
Novartis Pharmaceuticals Corporation, doing business as NPS, received a delivery order award from Veterans Integrated Service Network 4 on January 1, 2026, for the supply of radiopharmaceuticals, specifically Lutathera and Pluvicto injections. The firm fixed-price contract carries a ceiling value of $1.98M and is scheduled for completion by December 31, 2026. This award was made without a small business set-aside designation and is placed against Novartis' existing Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with performance to be fulfilled in Lebanon, Pennsylvania.
As a leading pharmaceutical manufacturer specializing in cancer therapy and nuclear medicine products, Novartis provides these specialized radiopharmaceuticals to support the Department of Veterans Affairs' healthcare delivery to veterans. This delivery order is one of multiple federal procurements for Lutathera and Pluvicto through the VA system, reflecting the company's established role as a key supplier of advanced oncological treatments to the federal government. The radiopharmaceuticals delivered under this contract support targeted cancer therapies within the VA's integrated service network structure.
Quick answers
Who was awarded contract 36C24426F0063?
36C24426F0063 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 4 (Veterans Health Administration) on January 1, 2026.
How much is contract 36C24426F0063 worth?
The government has obligated $1,980,571 on 36C24426F0063.
Is contract 36C24426F0063 an order under another contract?
Yes. 36C24426F0063 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24426F0063 competed?
The extent of competition for 36C24426F0063 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award